Floatz logo

Ciprofloxacin

Hematopoietic And Lymphoid System Neoplasm

Hospital Universitari Vall d'Hebron Research InstituteSmall moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

133 Active assets in the Hematopoietic And Lymphoid System Neoplasm cohort.

Asset / SponsorPhaseRating
Adriamycin
OHSU Knight Cancer Institute
Phase 4BBB
Dexasone
City of Hope Medical Center
Phase 3BB
Teclistamab
Janssen Pharmaceutical K.K.
Phase 2BB
Bortezomib
OHSU Knight Cancer Institute
Phase 4BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

Ciprofloxacin is also rated in:

bronchiectasisActive
BBB
Indicative · Phase 4
76 / 100
View asset →
infectious diseaseDormant
BBB
Indicative · Phase 4
72 / 100
View asset →
chronic obstructive pulmonary diseaseDormant
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →